{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:05:34Z","timestamp":1784019934879,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We conceptualize the Real-World Reassessment Threshold (RWRT) as representing the smallest change that exceeds expected measurement variability while accounting for clinically expected cognitive decline over the assessment interval, whereas the minimum clinically important difference (MCID) indicates the smallest change likely to be clinically meaningful. To date, no study has empirically defined the RWRT or MCID for Mini-Mental State Examination (MMSE) scores in Lewy body dementia (LBD) or frontotemporal dementia (FTD), limiting the interpretation of longitudinal changes and clinical trial designs. We therefore aimed to estimate 12-month, diagnosis-specific MMSE thresholds for RWRT and MCID among individuals with LBD and FTD, and to evaluate the generalizability of these thresholds in an independent validation cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This registry-based cohort study included individuals diagnosed with LBD or FTD from the Swedish Registry for Cognitive\/Dementia Disorders (SveDem, 2007\u20132022) with a 91\u2013400-day MMSE follow-up, and an independent validation cohort from the U.S. National Alzheimer\u2019s Coordinating Center (NACC). The RWRT was estimated using distribution-based methods based on intraclass correlation coefficients (ICCs). MCID was estimated using both anchor-based and distribution-based (0.5 standard deviation) approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 1,158 individuals from SveDem (873 LBD, 285 FTD) and 1,060 individuals from NACC (469 LBD, 591 FTD). Over the 91\u2013400-day follow-up interval, MMSE scores demonstrated moderate to high reliability (ICC 0.70\u20130.90), corresponding to RWRT estimates ranged from 5 to 7 MMSE points. Anchor-based MCIDs differed by diagnosis, with a mean threshold of 0.7 points in LBD and 3.8 points in FTD in SveDem; similar diagnosis- and baseline severity-dependent patterns were observed in NACC. In contrast, distribution-based MCIDs were consistent across diagnoses, clustering around 2\u20133 MMSE points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MMSE changes of less than five points over one year may reflect expected test variability combined with expected individual decline. However, average changes of 2\u20133 points may still be meaningful when combined with a clinical anchor of change, depending on diagnosis and disease stage. These results emphasize the importance of using both RWRT and MCID when evaluating MMSE change and selecting clinical trial endpoints.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-026-02136-y","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T07:21:46Z","timestamp":1783754506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thresholds for meaningful change in Mini-Mental State Examination scores in rare dementias"],"prefix":"10.1186","volume":"18","author":[{"given":"Tamar","family":"Abzhandadze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh Tuan","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"\u00c5kerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Norgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Garc\u00eda Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjia","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Eriksdotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Garcia-Ptacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"11","key":"2136_CR1","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1001\/jamaneurol.2025.3307","volume":"82","author":"D Urso","year":"2025","unstructured":"Urso D, Giannoni-Luza S, Brayne C, Ray N, Logroscino G. Incidence and Prevalence of Frontotemporal Dementia: A Systematic Review and Meta-Analysis. JAMA Neurol. 2025;82(11):1144\u201352.","journal-title":"JAMA Neurol"},{"issue":"11","key":"2136_CR2","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1001\/jamaneurol.2013.3579","volume":"70","author":"R Savica","year":"2013","unstructured":"Savica R, Grossardt BR, Bower JH, Boeve BF, Ahlskog JE, Rocca WA. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol. 2013;70(11):1396\u2013402.","journal-title":"JAMA Neurol"},{"issue":"9","key":"2136_CR3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jamainternmed.2015.2152","volume":"175","author":"KK Tsoi","year":"2015","unstructured":"Tsoi KK, Chan JY, Hirai HW, Wong SY, Kwok TC. Cognitive Tests to Detect Dementia: A Systematic Review and Meta-analysis. JAMA Intern Med. 2015;175(9):1450\u20138.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2136_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/WAD.0000000000000473","volume":"36","author":"B Patel","year":"2022","unstructured":"Patel B, Irwin DJ, Kaufer D, Boeve BF, Taylor A, Armstrong MJ. Outcome Measures for Dementia With Lewy Body Clinical Trials: A Review. Alzheimer Dis Assoc Disord. 2022;36(1):64\u201372.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2136_CR5","doi-asserted-by":"publisher","first-page":"1382593","DOI":"10.3389\/fnagi.2024.1382593","volume":"16","author":"JLP Fieldhouse","year":"2024","unstructured":"Fieldhouse JLP, van Paassen DN, van Engelen ME, De Boer SCM, Hartog WL, Braak S, et al. The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials. Front Aging Neurosci. 2024;16:1382593.","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"2136_CR6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/archneur.61.7.1104","volume":"61","author":"A Slachevsky","year":"2004","unstructured":"Slachevsky A, Villalpando JM, Sarazin M, Hahn-Barma V, Pillon B, Dubois B. Frontal assessment battery and differential diagnosis of frontotemporal dementia and Alzheimer disease. Arch Neurol. 2004;61(7):1104\u20137.","journal-title":"Arch Neurol"},{"issue":"3","key":"2136_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3233\/JAD-161109","volume":"57","author":"MG Kramberger","year":"2017","unstructured":"Kramberger MG, Auestad B, Garcia-Ptacek S, Abdelnour C, Olmo JG, Walker Z, et al. Long-term cognitive decline in dementia with Lewy bodies in a large multicenter, international cohort. J Alzheimers Dis. 2017;57(3):787\u201395.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2136_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010357","volume":"6","author":"A Rongve","year":"2016","unstructured":"Rongve A, Soennesyn H, Skogseth R, Oesterhus R, Hortobagyi T, Ballard C, et al. Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study. BMJ Open. 2016;6(2):e010357.","journal-title":"BMJ Open"},{"issue":"2","key":"2136_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1017\/S1041610200006359","volume":"12","author":"L Han","year":"2000","unstructured":"Han L, Cole M, Bellavance F, McCusker J, Primeau F. Tracking cognitive decline in Alzheimer\u2019s disease using the mini-mental state examination: a meta-analysis. Int Psychogeriatr. 2000;12(2):231\u201347.","journal-title":"Int Psychogeriatr"},{"issue":"10","key":"2136_CR10","doi-asserted-by":"publisher","first-page":"e1031","DOI":"10.1212\/WNL.0000000000012450","volume":"97","author":"E Matar","year":"2021","unstructured":"Matar E, White SR, Taylor JP, Thomas A, McKeith IG, Kane JPM, et al. Progression of Clinical Features in Lewy Body Dementia Can Be Detected Over 6 Months. Neurology. 2021;97(10):e1031\u201340.","journal-title":"Neurology"},{"issue":"3","key":"2136_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000094870","volume":"22","author":"TW Chow","year":"2006","unstructured":"Chow TW, Hynan LS, Lipton AM. MMSE scores decline at a greater rate in frontotemporal degeneration than in AD. Dement Geriatr Cogn Disord. 2006;22(3):194\u20139.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"2136_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1212\/01.wnl.0000171343.43314.6e","volume":"65","author":"K Rascovsky","year":"2005","unstructured":"Rascovsky K, Salmon DP, Lipton AM, Leverenz JB, DeCarli C, Jagust WJ, et al. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 2005;65(3):397\u2013403.","journal-title":"Neurology"},{"issue":"1","key":"2136_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13195-023-01360-0","volume":"15","author":"B Petek","year":"2023","unstructured":"Petek B, Habel H, Xu H, Villa-Lopez M, Kalar I, Hoang MT, et al. Statins and cognitive decline in patients with Alzheimer\u2019s and mixed dementia: a longitudinal registry-based cohort study. Alzheimers Res Ther. 2023;15(1):220.","journal-title":"Alzheimers Res Ther"},{"issue":"17","key":"2136_CR14","doi-asserted-by":"publisher","first-page":"e2220","DOI":"10.1212\/WNL.0000000000011832","volume":"96","author":"H Xu","year":"2021","unstructured":"Xu H, Garcia-Ptacek S, J\u00f6nsson L, Wimo A, Nordstr\u00f6m P, Eriksdotter M. Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality. Neurology. 2021;96(17):e2220\u201330.","journal-title":"Neurology"},{"issue":"1","key":"2136_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12874-021-01228-7","volume":"21","author":"JA Watt","year":"2021","unstructured":"Watt JA, Veroniki AA, Tricco AC, Straus SE. Using a distribution-based approach and systematic review methods to derive minimum clinically important differences. BMC Med Res Methodol. 2021;21(1):41.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2136_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40035-022-00299-w","volume":"11","author":"F Rodriguez-Porcel","year":"2022","unstructured":"Rodriguez-Porcel F, Wyman-Chick KA, Abdelnour Ruiz C, Toledo JB, Ferreira D, Urwyler P, et al. Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations. Transl Neurodegener. 2022;11(1):24.","journal-title":"Transl Neurodegener"},{"issue":"10","key":"2136_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040297","volume":"4","author":"JP Vandenbroucke","year":"2007","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, G\u00f8tzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):e297.","journal-title":"PLoS Med"},{"issue":"2","key":"2136_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116538","volume":"10","author":"D Religa","year":"2015","unstructured":"Religa D, Fereshtehnejad SM, Cermakova P, Edlund AK, Garcia-Ptacek S, Granqvist N, et al. SveDem, the Swedish Dementia Registry - a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice. PLoS ONE. 2015;10(2):e0116538.","journal-title":"PLoS ONE"},{"issue":"4","key":"2136_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/01.wad.0000213865.09806.92","volume":"20","author":"JC Morris","year":"2006","unstructured":"Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord. 2006;20(4):210\u20136.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2136_CR20","unstructured":"SveDem. Svenska registret f\u00f6r kognitiva sjukdomar\/demenssjukdomar, \u00c5rsrapport 2021.; 2022."},{"key":"2136_CR21","volume-title":"National Alzheimer\u2019s coordinating center: NACC uniform data set (UDS) coding guidebook for initial visit packet","author":"J Morris","year":"2008","unstructured":"Morris J. National Alzheimer\u2019s coordinating center: NACC uniform data set (UDS) coding guidebook for initial visit packet. ADC Clinical Task Force: Washington University; 2008."},{"issue":"9","key":"2136_CR22","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","volume":"40","author":"TN Tombaugh","year":"1992","unstructured":"Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40(9):922\u201335.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2136_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000365637","volume":"43","author":"V Philipps","year":"2014","unstructured":"Philipps V, Amieva H, Andrieu S, Dufouil C, Berr C, Dartigues JF, et al. Normalized mini-mental state examination for assessing cognitive change in population-based brain aging studies. Neuroepidemiology. 2014;43(1):15\u201325.","journal-title":"Neuroepidemiology"},{"key":"2136_CR24","unstructured":"Socialstyrelsen. Nationella riktlinjer f\u00f6r v\u00e5rd och omsorg vid demenssjukdom. St\u00f6d f\u00f6r styrning och ledning.: Socialstyrelsen; 2017. Report No.: 2017\u201312\u20132"},{"issue":"11","key":"2136_CR25","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412\u20134.","journal-title":"Neurology"},{"key":"2136_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1017\/S1041610297004870","volume":"9","author":"JC Morris","year":"1997","unstructured":"Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 1997;9:173\u20136.","journal-title":"Int Psychogeriatr"},{"key":"2136_CR27","doi-asserted-by":"publisher","unstructured":"Seamon BA, Kautz SA, Bowden MG, Velozo CA. Revisiting the concept of minimal detectable change for patient-reported outcome measures. Phys Ther. 2022;102(8):pzac068. https:\/\/doi.org\/10.1093\/ptj\/pzac068.\u00a0PMID: 35670017; PMCID: PMC9361333.","DOI":"10.1093\/ptj\/pzac068"},{"issue":"4","key":"2136_CR28","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3233\/JAD-215564","volume":"87","author":"KL Webb","year":"2022","unstructured":"Webb KL, Ryan J, Wolfe R, Woods RL, Shah RC, Murray AM, et al. Test-retest reliability and minimal detectable change of four cognitive tests in community-dwelling older adults. J Alzheimers Dis. 2022;87(4):1683\u201393.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"2136_CR29","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jclinepi.2005.10.015","volume":"59","author":"HC de Vet","year":"2006","unstructured":"de Vet HC, Terwee CB, Knol DL, Bouter LM. When to use agreement versus reliability measures. J Clin Epidemiol. 2006;59(10):1033\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2136_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/1545968309356295","volume":"24","author":"KC Lin","year":"2010","unstructured":"Lin KC, Fu T, Wu CY, Wang YH, Liu JS, Hsieh CJ, et al. Minimal detectable change and clinically important difference of the Stroke Impact Scale in stroke patients. Neurorehabil Neural Repair. 2010;24(5):486\u201392.","journal-title":"Neurorehabil Neural Repair"},{"issue":"5","key":"2136_CR31","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","volume":"41","author":"GR Norman","year":"2003","unstructured":"Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582\u201392.","journal-title":"Med Care"},{"issue":"1","key":"2136_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10433-020-00572-9","volume":"18","author":"C Hornsten","year":"2021","unstructured":"Hornsten C, Littbrand H, Bostrom G, Rosendahl E, Lundin-Olsson L, Nordstrom P, et al. Measurement error of the Mini-Mental State Examination among individuals with dementia that reside in nursing homes. Eur J Ageing. 2021;18(1):109\u201315.","journal-title":"Eur J Ageing"},{"issue":"1","key":"2136_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12877-021-02732-7","volume":"22","author":"Y-C Lee","year":"2022","unstructured":"Lee Y-C, Lee S-C, Chiu E-C. Practice effect and test-retest reliability of the Mini-Mental State Examination-2 in people with dementia. BMC Geriatr. 2022;22(1):67.","journal-title":"BMC Geriatr"},{"issue":"7","key":"2136_CR34","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1001\/archneur.56.7.857","volume":"56","author":"CM Clark","year":"1999","unstructured":"Clark CM, Sheppard L, Fillenbaum GG, Galasko D, Morris JC, Koss E, et al. Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer\u2019s Disease. Arch Neurol. 1999;56(7):857\u201362.","journal-title":"Arch Neurol"},{"issue":"5","key":"2136_CR35","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1002\/alz.13770","volume":"20","author":"RT Muir","year":"2024","unstructured":"Muir RT, Hill MD, Black SE, Smith EE. Minimal clinically important difference in Alzheimer\u2019s disease: rapid review. Alzheimers Dement. 2024;20(5):3352\u201363.","journal-title":"Alzheimers Dement"},{"key":"2136_CR36","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.trci.2019.06.005","volume":"5","author":"JS Andrews","year":"2019","unstructured":"Andrews JS, Desai U, Kirson NY, Zichlin ML, Ball DE, Matthews BR. Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer\u2019s disease clinical trials. Alzheimers Dement (N Y). 2019;5:354\u201363.","journal-title":"Alzheimers Dement (N Y)"},{"key":"2136_CR37","first-page":"509","volume":"10","author":"M Bruun","year":"2018","unstructured":"Bruun M, Rhodius-Meester HFM, Koikkalainen J, Baroni M, Gjerum L, Lemstra AW, et al. Evaluating combinations of diagnostic tests to discriminate different dementia types. Alzheimers Dement Diagn Assess Dis Monit. 2018;10:509\u201318.","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"issue":"1","key":"2136_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","volume":"16","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA, Korczyn AD. Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease? BMC Med. 2018;16(1):34.","journal-title":"BMC Med"},{"issue":"11","key":"2136_CR39","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1136\/jnnp-2013-307483","volume":"86","author":"JR Burrell","year":"2015","unstructured":"Burrell JR, Piguet O. Lifting the veil: how to use clinical neuropsychology to assess dementia. J Neurol Neurosurg Psychiatry. 2015;86(11):1216\u201324.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2136_CR40","volume":"6","author":"E Lindvall","year":"2024","unstructured":"Lindvall E, Abzhandadze T, Quinn TJ, Sunnerhagen KS, Lundstr\u00f6m E. Is the difference real, is the difference relevant: the minimal detectable and clinically important changes in the Montreal Cognitive Assessment. Cereb Circ Cogn Behav. 2024;6:100222.","journal-title":"Cereb Circ Cogn Behav"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02136-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:24:48Z","timestamp":1784017488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02136-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2136"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02136-y","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Swedish Ethical Review Authority (2024\u201308463-01). Data were extracted and anonymized from electronic records. The Swedish Ethical Review Authority, in accordance with the Personal Data Act (Swedish law No. SFS 1998:204), waived patient consent for this study. Participants were informed about registration in SveDem and their right to deny participation (opt-out consent). The NACC database collected data with written informed consent at the contributing centers; all analyses used pseudonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ME has served as speaker and\/or consultant on dementia at sporadic advisory board meetings for Biogen, Bioarctic, Roche, Eli Lilly, and NovoNordisk. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}